Treatments for rare diseases are hard to create and expensive to deliver, but there is new hope for editing the software of ...

Series B financing in XyloCor Therapeutics to develop Novel Gene Therapy in Cardiovascular Disease Proceeds of financing will ...

Bryan Johnson, who’s spending hundreds of millions of dollars on treatments designed to extend his life, is many things to ...

Researchers have successfully repaired damaged mouse hearts using a protein from zebrafish. They discovered that the protein Hmga1 plays a key role in heart regeneration in zebrafish. In mice, this ...

Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy ...

The data suggests that Hmga1, a key protein for regenerating heart cells, could be a target for gene therapies that prevent cardiac failure.

Seven-year-old Archie Ennis has been diagnosed with Duchenne muscular dystrophy, a genetic condition that causes muscle ...

Researchers have discovered that the protein Hmga1, found in zebrafish, can repair damaged mouse hearts by reactivating ...

New Gene Therapy Reverses Heart Failure in Large Animal Model Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart ...

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

Moderate drinking was once thought to have benefits for the heart, but better research methods have thrown cold water on that ...

Enliven Therapeutics' ELVN-001 shows promising results for CML patients. Click here to read what makes ELVN stock a ...